Cite
HARVARD Citation
Deitelzweig, S. et al. (2022). Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. Current medical research and opinion. pp. 1891-1896. [Online].